Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study

被引:94
作者
Qian, Ying [1 ]
McGraw, Sarah [2 ]
Henne, Jeff [2 ]
Jarecki, Jill [3 ]
Hobby, Kenneth [3 ]
Yeh, Wei-Shi [4 ]
机构
[1] SMA Fdn, New York, NY 10106 USA
[2] Henne Grp, San Francisco, CA 94105 USA
[3] Cure SMA, Elk Grove Village, IL 60007 USA
[4] Biogen Inc, Cambridge, MA 02142 USA
关键词
Spinal Muscular Atrophy (SMA); Patient; Parent; Diagnosis; Screening; Life impact; Qualitative; FUNCTIONAL MOTOR SCALE; CONSENSUS STATEMENT; NATURAL-HISTORY; OF-LIFE; CHILDREN; ADOLESCENTS; DIAGNOSIS; ATTITUDES; STANDARD; RESCUES;
D O I
10.1186/s12883-015-0473-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The clinical features of SMA, which range along a spectrum of severity, are relatively well described. In contrast, the literature on how individuals with SMA and their families experience this condition is limited. To address this gap, we undertook a qualitative study with individuals affected by SMA Types I, II and III, parents of those affected, and clinicians. Methods: We completed 16 focus group sessions and 37 interviews in the US with 96 participants including: 21 with individuals with SMA; 64 parents of individuals affected by SMA; and 11 clinicians who specialize in the care of SMA patients. Results: The Diagnostic Journey: Families reported substantial diagnostic delays owing to: 1) lack of awareness and knowledge about SMA; 2) the difficulty of distinguishing normal from abnormal development; and 3) the challenge of differential diagnosis. Lack of sensitivity in how clinicians communicated this potentially devastating diagnosis compounded parents' negative impressions. Newborn Screening: Parents generally held positive views about adding SMA to newborn screening panels. For example, it would: 1) enable earlier access to care; 2) shorten the diagnostic journey; and 3) give families more time to prepare to care for a disabled child. Some noted negative outcomes such as prematurely affecting a parent's relationship with a child before symptoms are evident. The Psychosocial Impact of Living with SMA: Ten thematic areas characterized the impact: 1) confronting premature death; 2) making difficult treatment choices; 3) fearing the loss of functional ability; 4) coming to terms with lost expectations; 5) loss of sleep and stress; 6) stigma; 7) limitations on social activities; 8) independence; 9) uncertainty and helplessness; and 10) family finances. Conclusions: The results of this study suggest high levels of burden experienced by individuals with SMA and their families. The difficulties of living with SMA begin with the long and often arduous process of finding a diagnosis for their child. Newborn screening for SMA is seen as an important step toward shortening this journey. The psychosocial effects of coping with SMA are substantial and wide ranging both for the individual living with this condition and family members of affected individuals.
引用
收藏
页数:12
相关论文
共 39 条
  • [1] [Anonymous], IDENTIFICATION AND C, DOI DOI 10.1016/0092-8674(95)90460-3
  • [2] SPINAL MUSCULAR ATROPHY: DIAGNOSIS AND MANAGEMENT IN A NEW THERAPEUTIC ERA
    Arnold, W. David
    Kassar, Darine
    Kissel, John T.
    [J]. MUSCLE & NERVE, 2015, 51 (02) : 157 - 167
  • [3] Parental Permission for Pilot Newborn Screening Research: Guidelines From the NBSTRN
    Botkin, Jeffrey R.
    Lewis, Michelle Huckaby
    Watson, Michael S.
    Swoboda, Kathryn J.
    Anderson, Rebecca
    Berry, Susan A.
    Bonhomme, Natasha
    Brosco, Jeffrey P.
    Comeau, Anne M.
    Goldenberg, Aaron
    Goldman, Edward
    Therrell, Bradford
    Levy-Fisch, Jill
    Tarini, Beth
    Wilfond, Benjamin
    [J]. PEDIATRICS, 2014, 133 (02) : E410 - E417
  • [4] Qualitative data analysis for health services research: Developing taxonomy, themes, and theory
    Bradley, Elizabeth H.
    Curry, Leslie A.
    Devers, Kelly J.
    [J]. HEALTH SERVICES RESEARCH, 2007, 42 (04) : 1758 - 1772
  • [5] Spinal muscular atrophy: Survival pattern and functional status
    Chung, BHY
    Wong, VCN
    Ip, P
    [J]. PEDIATRICS, 2004, 114 (05) : E548 - E553
  • [6] Self-reported quality of life has no correlation with functional status in children and adolescents with spinal muscular atrophy
    de Oliveira, Cristiane M.
    Araujo, Alexandra P. de Q. C.
    [J]. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2011, 15 (01) : 36 - 39
  • [7] Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR:: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy
    Feldkötter, M
    Schwarzer, V
    Wirth, R
    Wienker, TF
    Wirth, B
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (02) : 358 - 368
  • [8] Finkel RS, 2014, NEUROLOGY, V83, P810, DOI 10.1212/WNL.0000000000000741
  • [9] Validation of the Expanded Hammersmith Functional Motor Scale in Spinal Muscular Atrophy Type II and III
    Glanzman, Allan M.
    O'Hagen, Jessica M.
    McDermott, Michael P.
    Martens, William B.
    Flickinger, Jean
    Riley, Susan
    Quigley, Janet
    Montes, Jacqueline
    Dunaway, Sally
    Deng, Liyong
    Chung, Wendy K.
    Tawil, Rabi
    Darras, Basil T.
    De Vivo, Darryl C.
    Kaufmann, Petra
    Finkel, Richard S.
    [J]. JOURNAL OF CHILD NEUROLOGY, 2011, 26 (12) : 1499 - 1507
  • [10] Glaser B.G., 1978, THEORETICAL SENSITIV, DOI DOI 10.4324/9780203793206